Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-25 @ 3:02 AM
NCT ID:
NCT05940233
Eligibility Criteria:
Inclusion Criteria:
* Diafnoed Early pregnancy loss by TVS according to ACOG Practice bulletin 2018
* GA \<= 14 weeks
* Os open \<= 1 cm and no conceptus per os
* Hematicrit \>= 30
* Systolic blood pressure \>= 95 mmHg
* Informed consent done and can follow up and comunicate in Thai language
Exclusion Criteria:
* Allerguc to Letrozole or Misoprostol
* Intrauterine contraceptive device use
* Breast feeding
* Diagnoed with ectopic pregnancy or undiagnoed adnexal mass
* Severe or recurrent liver disease or AST or ALT more than or equal to 3 times of upper normal limit
* Multiple pregnancy
* Myoma uteri that involves the endometrium ex. Submucous myoma uteri
* Thromboembolism or has a history of thromboembolism
* Serum creatinine \>= 2
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT05940233
Study Brief:
Protocol Section:
NCT05940233